Elaine Husni, MD, MPH, on IV Golimumab Versus Placebo in Patients With Psoriatic Arthritis
MedPage Today,
American College of Rheumatology > Psoriatic Arthritis Findings may be worth discussing with patients who dislike needles and…
American College of Rheumatology > Psoriatic Arthritis Findings may be worth discussing with patients who dislike needles and…
M. Elaine Husni Intravenous golimumab, in doses of 2 mg per kg, reduced the signs and symptoms of psoriatic arthritis through1…
Results from a randomized controlled trial published in Arthritis Care